SEC Comment Letter 0000000000-23-006468 to EKSO BIONICS HOLDINGS, INC. (EKSO)
EKSO BIONICS HOLDINGS, INC.
Date: June 15, 2023 · CIK: 0001549084 · Accession: 0000000000-23-006468
AI Filing Summary & Sentiment
File numbers found in text: 333-272607
Letter
United States securities and exchange commission logo June 15, 2023 Scott Davis Chief Executive Officer Ekso Bionics Holdings, Inc. 101 Glacier Point, SuiteA San Rafael, California 94901 Re:Ekso Bionics Holdings, Inc. Registration Statement on Form S-3 Filed June 12, 2023 File No. 333-272607 Dear Scott Davis: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Kyle Wiley, Staff Attorney, at (202) 344-5791 or Jan Woo, Legal Branch Chief, at (202) 551-3453 with any questions. Sincerely, Division of Corporation Finance Office of Technology cc: Austin March
Show Raw Text
United States securities and exchange commission logo
June 15, 2023
Scott Davis
Chief Executive Officer
Ekso Bionics Holdings, Inc.
101 Glacier Point, SuiteA
San Rafael, California 94901
Re:Ekso Bionics Holdings, Inc.
Registration Statement on Form S-3
Filed June 12, 2023
File No. 333-272607
Dear Scott Davis:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Kyle Wiley, Staff Attorney, at (202) 344-5791 or Jan Woo, Legal Branch
Chief, at (202) 551-3453 with any questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc: Austin March